Lidocaine Hydrochloride Injection, Solution
Product Images NDC 51662-1454

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lidocaine Hydrochloride (NDC 51662-1454). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Rfid Label (51662 1454 1 Rfid Label)

This is a product label with the manufacturer's information, distributor's details, and a note to refer to the manufacturer's insert for further instructions. The product seems to be distributed by HF Acquisitions Co., LLC based in Mukilteo, WA. The text also includes a code starting with "(81)" which may represent a product or reference number for the item. *

FDA Label Image

Structure (51662 1454 1 Structure)

FDA Label Image

Carton Label (51662 1454 1 Carton Label)

This text describes the process of using a syringe with Lidocaine HCI Injection, USP with a concentration of 20 mg/mL. It provides instructions to follow aseptic technique, remove the luer cover, push the plunger forward to relieve the injection, pull the barrel down to expel air, and has information on the lot number, expiration date, and manufacturing details. The product is distributed by Hospira, Inc. Made in Spain.*

FDA Label Image

Table 1 (51662 1454 1 Table 1)

This is an information table providing details about Lidocaine solution in a 5 mL volume for direct intravenous injection, with a concentration of 10 mg/mL and a total of 50 mg Lidocaine Hydrochloride.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.